#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Transient ischaemic attack Red blood cell abnormality Squamous cell carcinoma of head and neck CDKL5 deficiency disorder Chronic hepatitis B NTRK gene fusion overexpression Thyroid cancer metastatic Adrenogenital syndrome Angelman's syndrome Ewing's sarcoma Pleomorphic liposarcoma Rectal cancer Myotonia Juvenile chronic myelomonocytic leukaemia Andersen-Tawil syndrome More trials…

    Learn about Rare Diseases

    Haemophilia Pulmonary fibrosis Breast angiosarcoma – Trials in Disease Rett syndrome – Life with Disease Myelodysplastic syndrome – Basic Information Urea cycle disorder – Diagnostics Alport’s syndrome – Trials in Disease Leiomyosarcoma recurrent – Diagnostics Pelizaeus-Merzbacher disease – Life with Disease Antithrombin III deficiency More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Carbamazepine (Ph. Eur.) NERANDOMILAST Diclofenac Sodium Yttrium-90 Rtx001 Fosfomycin Spesolimab Varenicline Ict01 HLX43 Ethambutol Degarelix Gefitinib Elenestinib Phosphate Tiragolumab Trifluridine Bms-986435 Doxylamine Hydrogen Succinate Tumour Detection Lanifibranor More therapies…

    Learn about Your Condition

    Malignant peritoneal neoplasm Brain abscess Angiosarcoma recurrent Incisional hernia Lymphocytic lymphoma Langerhans cell sarcoma Angiopathy Thyroid mass Eosinophilic oesophagitis Adenovirus infection Progressive supranuclear palsy Laparotomy Adrenal insufficiency Anxiety disorder Osteonecrosis of jaw More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Using Desmopressin Acetate Trihydrate to Prevent Sodium Overcorrection in Patients with Severe Hyponatremia

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Sodium Lactate
    • Meglumine Gadoterate
    • Glucose Monohydrate
    France

  • Study of drug combination in patients with advanced cancer based on genomic profiling – ProTarget Danish nationwide trial

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Cobimetinib
    • Niraparib
    • Pemigatinib
    Denmark

  • Study of Epoetin Alfa for Critically Ill Patients with Traumatic Injury

    Recruiting

    3 1 1
    Investigated Diseases:
    • Critical illness
    Investigated Drugs:
    • Epoetin Alfa
    Belgium Finland France Germany Ireland Slovenia

  • Study on the Effects of Histamine Dihydrochloride and Aldesleukin in Patients with Resectable Pancreatic Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Histamine Dihydrochloride
    • Aldesleukin
    Sweden

  • Dose-Reduced Oxaliplatin and Drug Combination Study for Older Patients with Metastatic Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Capecitabine
    • Folinic Acid
    • Fluorouracil
    The Netherlands

  • Study on Placental Blood Flow in Fetal Growth Restriction Using Sulfur Hexafluoride for Patients Undergoing Medical Termination of Pregnancy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Foetal growth restriction
    Investigated Drugs:
    • Sulfur Hexafluoride
    France
Previous Page
1 … 485 486 487 488 489 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!